# Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers

> **NCT00421226** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 48 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ACZ885

## Key facts

- **NCT ID:** NCT00421226
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421226, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00421226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*